GERN - Financial Reports List - Geron Corporation - IntrinsicAlpha

Geron Corporation GERN

Healthcare - Biotechnology - NASDAQ - US

$ 1.32

6.3 %

$ 841 M

Market Cap

-5.0

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	206582.61%	51.22%	63.07%
Annual Report	FY	10-K	2024-12-31	32386.92%	5.19%	10.42%
Quarterly Report	Q3	8-K	2024-09-30	17138.41%	40.97%	40.74%
Quarterly Report	Q2	8-K	2024-06-30	2941.38%	-36.88%	-33.46%
Quarterly Report	Q1	8-K	2024-03-31	1347.62%	-45.48%	-40.01%
Quarterly Report	Q4	8-K	2023-12-31	-77.67%	-22.56%	-29.41%
Annual Report	FY	10-K	2023-12-31	-60.23%	-30.56%	-39.98%
Quarterly Report	Q3	8-K	2023-09-30	-44.78%	-9.75%	-19.18%
Quarterly Report	Q2	8-K	2023-06-30	-60.27%	-74.21%	-85.70%
Quarterly Report	Q1	8-K	2023-03-31	-82.93%	-20.79%	-39.82%

1